Forum Day 2019


2x CEO Forums for private early stage and private growth / late growth stage executives to uncover KSFs relating to their company stage.

12:00


Registration and Networking Lunch

13:00

Choose from 2 CEO Forums:


LSX Early Stage CEO Forum 200x    hosted by     Wilson Sonsini     LaVoie Health Science 300x

A unique, powerful and valuable space for the candid sharing of experience between 30-40 of the sector’s pre-series A life science executives. A pre-registration only, exclusive hollow square forum where all participants are active discussants.

Session Moderator: Paul Sagan, Assistant VP, Investor Relations, LaVoie Health Science

13.00 - Intro from moderator, hosts and 60sec elevator pitch from all executives in the room

13.15 - Case study: non-dilutive funding to advance R&D
Jeff Behrens, President & CEO, Siamab Therapeutics

13.30 - Q&A

13.45 - Case study: anatomy of a first round financing
Mark R. Fitzgerald, Partner, Wilson Sonsini Goodrich & Rosati and James Sietstra, Co-founder, Totient, Inc.

14.30 - Q&A

14.45 - Case study: international Investment and Company Building: Oncologie A + B with Asian investment partners
Laura Benjamin, Founder & CEO, Oncologie

15.00 - Q&A

15.15 - Afternoon Break

Session Moderator: Sharon Choe, SVP, IR and Business Development, LaVoie Health Science

15.45 - Presentation: how to create your life Science company presentation in just 15 slides 
Donna LaVoie, President & CEO, LaVoie Health Science

16.15 - Q&A

16.30 - Case study: following an asset centric approach to growing your business
Arthur Hiller, CEO, Antyllus Therapeutics, Inc. 

16.45 - Q&A

17.00 - Case study: the wisdom of fundraising, combination products and building a business
Christopher Stepanian, CEO, WindGap Medical 

17.15 - Q&A

17.30 - General macro challenge discussion not restricted to valuation, alternative growth strategies and research partnerships
Executives will have the opportunity to highlight areas of interest prior to the afternoon break to aggregate themes for this 30mins session.

18.00 - Networking Drinks followed by CEO Dinner

 

OR


LSX Growth Stage CEO Forum 200x      co-hosted by        IQVIA 300x-1     Morrison & Foerster 300x

A unique, powerful and valuable space for the candid sharing of experience between 30-40 of the sector’s post-series A life science executives. A pre-registration only, exclusive hollow square forum where all participants are active discussants.

Session Moderator: John Hodgson, Director, PersComm Ltd.

13.00 - Intro from moderator, hosts and 60sec elevator pitch from all executives in the room

13.15 - Case study: challenges in securing later stage investment
Dan Grau, CEO, Sojournix

13.30 - Q&A

13.45 - Case study: legal and business challenges in securing late stage financing
Ori Solomon, Partner, Corporate Department and Co-chair, Emerging Companies and Venture Capital, Morrison Foerster

14.00 - Q&A

14.15 - Case study: considerations for a commercialization model: how to optimize value to patients and stakeholders
Jay Margolis, VP and GM, Strategy and Portfolio Planning, IQVIA

14.45 - Q&A

15.00 - Afternoon Break

15.30 - Case study: taking your products through the clinic / clinical / R&D strategies
Adam Rosenberg, CEO, Rodin Therapeutics

15.45 - Q&A

16.00 - Case study: finding new directions for success after clinical failures
Neal Farber, CEO, NeuroHealing Pharmaceuticals  

16.15 - Q&A

16.30 - Case study: M&A as a strategic multiplier
Satish Sanan, Chairman and CEO, Inspirata, Inc.

16.45 - Q&A

17.00 - Case study: preparing commercial go-to-market, strategies and activities
John Glasspool, CEO, Anthos Therapeutics

17.15 - Q&A

17.30 - Plus General macro challenge discussion not restricted to valuations and dilutions, research partnerships, market access, pricing and exit dynamics
Executives will have the opportunity to highlight areas of interest prior to the afternoon break to aggregate themes for this 30mins session.

18.00 - Networking Drinks followed by CEO Dinner

17:30


Networking Drinks & CEO Dinners

DOWNLOAD THE BROCHURE